OUR STORY
Brinter began with a bold question:
What if human tissue could be 3D bioprinted like something out of science fiction?
2018
Founded in Finland in 2018 by serial tech founder CEO Tom Alapaattikoski and Tomi Kalpio, a automotive manufacturing plant inventor, Brinter was inspired by sci-fi worlds seen in Blade Runner (’82), The Fifth Element (’97), and Westworld (’16) — stories where tech rebuilds the human body.
2021
In 2021, after completing its multi-material 3D bioprinting platform, Brinter moved its HQ to the US to pioneer regenerative 3D bioprinted implants. Despite immense R&D challenges in both mechanical and biological engineering, Brinter remained committed to the grand vision.
2026
Today, in 2026, Brinter is fast approaching the commercialization of the first-ever 3D bioprinted regenerative implant in the United States. Our mission is simple: to make regenerative implants for the entire human body accessible to everyone.
Meet Our Visionary Leaders
Our leadership team combines serial entrepreneurship with expertise in deep technology to drive innovation in 3D bioprinting and regenerative medicine.
Surgeon Advisory Board
Our KOL team's deep expertise in medicine drives innovation. They play a crucial role in advancing our mission to improve healthcare solutions.
Dr Allen Deutsch
Dr Andrew Wickline
Dr Selene Parekh
Dr Alexander Aleem
Dr Rajan M. Patel
Dr Matthew V Jenkins
Dr Shariff K Bishai